Related references
Note: Only part of the references are listed.Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery
Erik N. Hansen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Laparoscopic Roux-En-Y Gastric Bypass Significant Long-Term Weight Loss, Improvement of Obesity-Related Comorbidities and Quality of Life
Michel Suter et al.
ANNALS OF SURGERY (2011)
Gastric bypass surgery, but not caloric restriction, decreases dipeptidyl peptidase-4 activity in obese patients with type 2 diabetes
M. L. Alam et al.
DIABETES OBESITY & METABOLISM (2011)
Early Improvement in Glycemic Control After Bariatric Surgery and Its Relationships with Insulin, GLP-1, and Glucagon Secretion in Type 2 Diabetic Patients
Luciana Mela Umeda et al.
OBESITY SURGERY (2011)
A Model for Predicting the Resolution of Type 2 Diabetes in Severely Obese Subjects Following Roux-en Y Gastric Bypass Surgery
Mark Thomas Hayes et al.
OBESITY SURGERY (2011)
Gut Hypertrophy After Gastric Bypass Is Associated With Increased Glucagon-Like Peptide 2 and Intestinal Crypt Cell Proliferation
Carel W. le Roux et al.
ANNALS OF SURGERY (2010)
Remission of Type 2 Diabetes After Gastric Bypass and Banding Mechanisms and 2 Year Outcomes
Dimitrios J. Pournaras et al.
ANNALS OF SURGERY (2010)
Prospective study of health-related quality of life after Roux-en-Y bypass surgery for morbid obesity
C. -Y. Chang et al.
BRITISH JOURNAL OF SURGERY (2010)
Postprandial Diabetic Glucose Tolerance Is Normalized by Gastric Bypass Feeding as Opposed to Gastric Feeding and Is Associated With Exaggerated GLP-1 Secretion - A case report
Carsten Dirksen et al.
DIABETES CARE (2010)
The Importance of Caloric Restriction in the Early Improvements in Insulin Sensitivity After Roux-en-Y Gastric Bypass Surgery
James M. Isbell et al.
DIABETES CARE (2010)
Meal-Induced Hormone Responses in a Rat Model of Roux-en-Y Gastric Bypass Surgery
Andrew C. Shin et al.
ENDOCRINOLOGY (2010)
Ileal Interposition Surgery Improves Glucose and Lipid Metabolism and Delays Diabetes Onset in the UCD-T2DM Rat
Bethany P. Cummings et al.
GASTROENTEROLOGY (2010)
Preoperative Factors Predicting Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery for Obesity
Tom C. Hall et al.
OBESITY SURGERY (2010)
Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass
N. Hamza et al.
Surgery for Obesity and Related Diseases (2010)
Mechanisms of Glucose Homeostasis After Roux-en-Y Gastric Bypass Surgery in the Obese, Insulin-Resistant Zucker Rat
Katia Meirelles et al.
ANNALS OF SURGERY (2009)
Results of Roux-en-Y Gastric Bypass in Morbidly Obese vs Superobese Patients Similar Body Weight Loss, Correction of Comorbidities, and Improvement of Quality of Life
Michel Suter et al.
ARCHIVES OF SURGERY (2009)
TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
Charles Thomas et al.
CELL METABOLISM (2009)
Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling?
F. K. Knop
DIABETOLOGIA (2009)
Long-Term Effects of Roux-en-Y Gastric Bypass Surgery on Plasma Glucagon-Like Peptide-1 and Islet Function in Morbidly Obese Subjects
Josep Vidal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism
Mary-Elizabeth Patti et al.
OBESITY (2009)
GLP-1 and Adiponectin: Effect of Weight Loss After Dietary Restriction and Gastric Bypass in Morbidly Obese Patients with Normal and Abnormal Glucose Metabolism
Camila Puzzi de Carvalho et al.
OBESITY SURGERY (2009)
Standardization of the Fully Stapled Laparoscopic Roux-en-Y Gastric Bypass for Obesity Reduces Early Immediate Postoperative Morbidity and Mortality: A Single Center Study on 2606 Patients
Bruno Dillemans et al.
OBESITY SURGERY (2009)
Five-year outcome with gastric bypass: Roux limb length makes a difference
John J. Gleysteen
SURGERY FOR OBESITY AND RELATED DISEASES (2009)
Incretin and islet hormonal responses to fat and protein ingestion in healthy men
Richard D. Carr et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Adjustable gastric banding and conventional therapy for type 2 diabetes - A randomized controlled trial
John B. Dixon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes
Blandine Laferrere et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Preoperative weight loss is not a predictor of postoperative weight loss after laparoscopic Roux-en-Y gastric bypass
Arthur M. Carlin et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2008)
Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass
Carel W. le Roux et al.
ANNALS OF SURGERY (2007)
Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding
Judith Korner et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2007)
Long-term mortality after gastric bypass surgery
Ted D. Adams et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: A preliminary study
Bryan A. Whitson et al.
JOURNAL OF SURGICAL RESEARCH (2007)
Influence of complications and extent of weight loss on quality of life after laparoscopic Roux-en-Y gastric bypass
J. D. Rea et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2007)
Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes
Blandine Laferrere et al.
DIABETES CARE (2007)
Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects
R Morínigo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety
CM Borg et al.
BRITISH JOURNAL OF SURGERY (2006)
Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters
CW le Roux et al.
ANNALS OF SURGERY (2006)
The neurotransmitters glycine and GABA stimulate glucagon-like peptide-1 release from the GLUTag cell line
A Gameiro et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)
Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model
S Suzuki et al.
SURGERY (2005)
Loss insulin resistance after roux-en-Y gastric bypass surgery: a time course study
K Wickremesekera et al.
OBESITY SURGERY (2005)
Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice
B Ahrén
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2004)
Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells
A Nakagawa et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2004)
Glutamine potently stimulates glucagon-like peptide-1 secretion from GLUTag cells
F Reimann et al.
DIABETOLOGIA (2004)
The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism
F Rubino et al.
ANNALS OF SURGERY (2004)
On the physiology of GIP and GLP-1
JJ Holst
HORMONE AND METABOLIC RESEARCH (2004)
Bariatric surgery: A systematic review and meta-analysis
H Buchwald et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia
JJ Meier et al.
DIABETOLOGIA (2003)
Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes
JJ Meier et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Interaction between specific fatty acids, GLP-1 and insulin secretion in humans
C Beysen et al.
DIABETOLOGIA (2002)
Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery.
DE Cummings et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes:: a parallel-group study
M Zander et al.
LANCET (2002)
Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats
PJ Larsen et al.
DIABETES (2001)
Reduced postprandial concentrations of intact biologically active gluccagon-like peptide 1 in type 2 diabetic patients
T Vilsboll et al.
DIABETES (2001)
Share Paper
